Republica Cehă - cehă - SUKL (Státní ústav pro kontrolu léčiv)

as kalceks, riga array - 18954 palonosetron-hydrochlorid - injekční roztok - 250mcg - palonosetron

Uniunea Europeană - cehă - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukemie, myeloid - antineoplastická činidla - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.

Uniunea Europeană - cehă - EMA (European Medicines Agency)

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastická činidla - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.

Uniunea Europeană - cehă - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - crisantaspase - prekurzorová buněčná lymfoblastická leukémie-lymfom - antineoplastická činidla - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.